Skip to content
MedsAcross

Brand family

Xalkori

Crizotinib · Pfizer Laboratories
United States
Presentations
5
Markets
1

Xalkori is a brand of Crizotinib marketed by Pfizer Laboratories, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Crizotinib
Brand owner
Pfizer Laboratories
Registered in
United States
Strengths and forms
150 mg capsule, 20 mg capsule, 200 mg capsule, 250 mg capsule, 50 mg capsule

All presentations

MedicineManufacturerRegisterAvailability
Xalkori 150 mg capsuleOralPfizer LaboratoriesUS FDAAvailable on request
Xalkori 20 mg capsuleOralPfizer LaboratoriesUS FDAAvailable on request
Xalkori 200 mg capsuleOralPfizer LaboratoriesUS FDAAvailable on request
Xalkori 250 mg capsuleOralPfizer LaboratoriesUS FDAAvailable on request
Xalkori 50 mg capsuleOralPfizer LaboratoriesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Xalkori

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.